Shares of Fangzhou Inc (06086.HK), a leading healthcare solutions provider in China, surged 7.62% in intraday trading on Tuesday, despite the company reporting a substantial loss for the first half of 2024.
According to the company's interim financial results, Fangzhou Inc recorded a 2.5% year-over-year increase in revenue to RMB 1,322.8 million for the six months ended June 30, 2024. However, the company also reported a loss and total comprehensive loss of RMB 818.7 million during the same period.
Despite the reported losses, investors seem to be focusing on the positive revenue growth, which may indicate that the company's underlying business operations are improving. The revenue increase could be attributed to higher demand for Fangzhou Inc's healthcare services and products, driven by factors such as an aging population and rising healthcare awareness in China.
Comments